Sign In   |   Join
Facility Innovations for Compounding Pharmacies
Tell a Friend About This EventTell a Friend

This presentation provides an understanding of the upcoming revision to USP 797 and new USP 800. It outlines the basic expectations for 503A & B facilities, including compounding of sterile, non-sterile and hazardous products. The intent of this interactive presentation is to review the USP standards, facility impacts, and discussion questions for the pharmacy professionals to identify their best path forward to compliance.

When: Tuesday, December 12, 2017
11:30 AM
Where: IPS - Integrated Project Services
6201 College Boulevard
Suite 175
Overland Park, Kansas  66211
United States
Contact: Komal Hatti
(913) 345-9084 s 5221

« Go to Upcoming Event List  

Overland Park, KS office of IPS-Integrated Project Services, LLC presents innovative facility solutions to address the future needs of 503A & 503B Compounding Pharmacies. Pharmaceutical compounding industry has been undergoing significant changes as a result of the recent FDA and USP regulation changes. At the same time, the future of medicine points to a greater need for individualized patient solutions. Compounding industry is expected to grow in size and complexity, to fulfil the demand for custom medication.

In collaboration with KansasBIO, DYNALABS, Formulet and SKAN, IPS presents an in-depth discussion on facility solutions that address compliance, safety and business concerns.



Association Management Software Powered by YourMembership  ::  Legal